STOCK TITAN

[Form 4/A] Mannatech Inc. Amended Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4/A
Rhea-AI Filing Summary

Mannatech Inc. (MTEX) reporting person Fredrick Landen Granvel, President and CEO, amended a Form 4 to correct the vesting schedule for a stock option grant dated 06/03/2025. The amendment states the options (20,000 shares underlying) have a three-year vesting schedule: one-third on each anniversary of the grant, with immediate vesting upon a change in control. The options have a $10.60 exercise price and expire 06/03/2035. The report also shows a sale of 3,975 shares of common stock and a total beneficial ownership of 44,000 shares following the transactions. The amendment corrects an earlier filing that contained an incorrect vesting schedule.

Mannatech Inc. (MTEX) — la persona segnalante Fredrick Landen Granvel, Presidente e CEO — ha modificato un Form 4 per correggere il calendario di maturazione (vesting) relativo a una concessione di opzioni su azioni datata 03/06/2025. L'emendamento indica che le opzioni (sottostanti a 20.000 azioni) maturano in tre anni: un terzo alla ricorrenza annuale del conferimento, con maturazione immediata in caso di cambio di controllo. Il prezzo di esercizio è di 10,60$ e le opzioni scadranno il 03/06/2035. Il documento riporta inoltre la vendita di 3.975 azioni ordinarie e una partecipazione beneficiaria totale pari a 44.000 azioni dopo le operazioni. L'amendamento corregge una precedente comunicazione che riportava un calendario di maturazione errato.

Mannatech Inc. (MTEX), persona informante Fredrick Landen Granvel, Presidente y CEO, enmendó un Form 4 para corregir el calendario de adquisición (vesting) de una concesión de opciones sobre acciones con fecha 03/06/2025. La enmienda señala que las opciones (respaldadas por 20.000 acciones) tienen un vesting de tres años: un tercio en cada aniversario de la concesión, con adquisición inmediata en caso de cambio de control. El precio de ejercicio es de 10,60$ y las opciones vencen el 03/06/2035. El informe también muestra la venta de 3.975 acciones ordinarias y una propiedad beneficiaria total de 44.000 acciones tras las transacciones. La enmienda corrige una presentación anterior que contenía un calendario de vesting incorrecto.

Mannatech Inc. (MTEX)의 신고인인 사장 겸 CEO Fredrick Landen Granvel은 2025-06-03일자 주식매수선택권 부여의 베스팅 일정 수정을 위해 Form 4를 수정 제출했습니다. 수정서에 따르면 해당 옵션(기초주식 20,000주)은 3년 베스팅으로, 부여일 매년 기념일에 1/3씩 베스트되며 경영권 변경 시 즉시 베스팅됩니다. 행사가격은 $10.60이고 만기일은 2035-06-03입니다. 보고서에는 또한 보통주 3,975주의 매도와 거래 후 총 실질 보유지분 44,000주가 기재되어 있습니다. 이 수정은 잘못된 베스팅 일정을 담은 이전 제출을 정정한 것입니다.

Mannatech Inc. (MTEX) — la personne déclarante Fredrick Landen Granvel, président et CEO — a modifié un Form 4 pour corriger le calendrier d'acquisition (vesting) d'une attribution d'options datée du 03/06/2025. L'amendement indique que les options (sous-jacentes à 20 000 actions) suivent un vesting sur trois ans : un tiers à chaque anniversaire de l'attribution, avec acquisition immédiate en cas de changement de contrôle. Le prix d'exercice est de 10,60$ et les options expirent le 03/06/2035. Le rapport signale également la vente de 3 975 actions ordinaires et une détention bénéficiaire totale de 44 000 actions après les opérations. L'amendement corrige un dépôt antérieur contenant un calendrier de vesting incorrect.

Mannatech Inc. (MTEX), meldepflichtige Person Fredrick Landen Granvel, Präsident und CEO, hat ein Form 4 abgeändert, um den Vesting-Zeitplan einer Aktienoptionszuteilung vom 03.06.2025 zu korrigieren. Die Änderung besagt, dass die Optionen (zugrunde liegende 20.000 Aktien) einem dreijährigen Vesting unterliegen: ein Drittel jeweils am Jahrestag der Zuteilung, mit sofortigem Vesting bei einem Kontrollwechsel. Der Ausübungspreis beträgt 10,60$ und die Optionen laufen am 03.06.2035 ab. Der Bericht vermerkt außerdem den Verkauf von 3.975 Stammaktien und eine gesamte wirtschaftliche Beteiligung von 44.000 Aktien nach den Transaktionen. Das Amendment korrigiert eine frühere Einreichung mit falschem Vesting-Zeitplan.

Positive
  • Clarified vesting schedule improves transparency by specifying one-third vesting each anniversary over three years.
  • Change-in-control acceleration provides clear terms that protect executive interests and are disclosed to investors.
  • Option grant details are explicit: 20,000 options at a $10.60 exercise price expiring 06/03/2035.
Negative
  • Insider sale of 3,975 shares reduces the reporting person's direct holdings.
  • Original Form 4 contained incorrect vesting information, requiring an amendment which may raise minor disclosure control questions.

Insights

TL;DR: CEO amended Form 4 fixing option vesting; 20,000 options granted at $10.60 with standard three-year vesting and change-in-control acceleration.

The amendment clarifies the vesting cadence for a material option grant rather than altering economics: 20,000 options exercisable through 2035 at $10.60 and vesting in three equal annual tranches. Such a schedule aligns management incentives with multi-year performance while the change-in-control acceleration provides common protection for executives. A contemporaneous sale of 3,975 shares reduces direct holdings but does not materially change total reported beneficial ownership of 44,000 shares.

TL;DR: Amendment corrects disclosure; vesting terms and change-in-control clause are explicit, improving transparency for investors.

Filing an amendment to correct vesting details improves disclosure quality and reduces ambiguity about executive compensation timing. The three-year cliff/annual tranche approach and explicit acceleration on change in control are common governance features. The record shows standard Section 16 reporting practices with a POA signature, and the corrected schedule helps investors assess potential dilution timing from option exercises.

Mannatech Inc. (MTEX) — la persona segnalante Fredrick Landen Granvel, Presidente e CEO — ha modificato un Form 4 per correggere il calendario di maturazione (vesting) relativo a una concessione di opzioni su azioni datata 03/06/2025. L'emendamento indica che le opzioni (sottostanti a 20.000 azioni) maturano in tre anni: un terzo alla ricorrenza annuale del conferimento, con maturazione immediata in caso di cambio di controllo. Il prezzo di esercizio è di 10,60$ e le opzioni scadranno il 03/06/2035. Il documento riporta inoltre la vendita di 3.975 azioni ordinarie e una partecipazione beneficiaria totale pari a 44.000 azioni dopo le operazioni. L'amendamento corregge una precedente comunicazione che riportava un calendario di maturazione errato.

Mannatech Inc. (MTEX), persona informante Fredrick Landen Granvel, Presidente y CEO, enmendó un Form 4 para corregir el calendario de adquisición (vesting) de una concesión de opciones sobre acciones con fecha 03/06/2025. La enmienda señala que las opciones (respaldadas por 20.000 acciones) tienen un vesting de tres años: un tercio en cada aniversario de la concesión, con adquisición inmediata en caso de cambio de control. El precio de ejercicio es de 10,60$ y las opciones vencen el 03/06/2035. El informe también muestra la venta de 3.975 acciones ordinarias y una propiedad beneficiaria total de 44.000 acciones tras las transacciones. La enmienda corrige una presentación anterior que contenía un calendario de vesting incorrecto.

Mannatech Inc. (MTEX)의 신고인인 사장 겸 CEO Fredrick Landen Granvel은 2025-06-03일자 주식매수선택권 부여의 베스팅 일정 수정을 위해 Form 4를 수정 제출했습니다. 수정서에 따르면 해당 옵션(기초주식 20,000주)은 3년 베스팅으로, 부여일 매년 기념일에 1/3씩 베스트되며 경영권 변경 시 즉시 베스팅됩니다. 행사가격은 $10.60이고 만기일은 2035-06-03입니다. 보고서에는 또한 보통주 3,975주의 매도와 거래 후 총 실질 보유지분 44,000주가 기재되어 있습니다. 이 수정은 잘못된 베스팅 일정을 담은 이전 제출을 정정한 것입니다.

Mannatech Inc. (MTEX) — la personne déclarante Fredrick Landen Granvel, président et CEO — a modifié un Form 4 pour corriger le calendrier d'acquisition (vesting) d'une attribution d'options datée du 03/06/2025. L'amendement indique que les options (sous-jacentes à 20 000 actions) suivent un vesting sur trois ans : un tiers à chaque anniversaire de l'attribution, avec acquisition immédiate en cas de changement de contrôle. Le prix d'exercice est de 10,60$ et les options expirent le 03/06/2035. Le rapport signale également la vente de 3 975 actions ordinaires et une détention bénéficiaire totale de 44 000 actions après les opérations. L'amendement corrige un dépôt antérieur contenant un calendrier de vesting incorrect.

Mannatech Inc. (MTEX), meldepflichtige Person Fredrick Landen Granvel, Präsident und CEO, hat ein Form 4 abgeändert, um den Vesting-Zeitplan einer Aktienoptionszuteilung vom 03.06.2025 zu korrigieren. Die Änderung besagt, dass die Optionen (zugrunde liegende 20.000 Aktien) einem dreijährigen Vesting unterliegen: ein Drittel jeweils am Jahrestag der Zuteilung, mit sofortigem Vesting bei einem Kontrollwechsel. Der Ausübungspreis beträgt 10,60$ und die Optionen laufen am 03.06.2035 ab. Der Bericht vermerkt außerdem den Verkauf von 3.975 Stammaktien und eine gesamte wirtschaftliche Beteiligung von 44.000 Aktien nach den Transaktionen. Das Amendment korrigiert eine frühere Einreichung mit falschem Vesting-Zeitplan.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fredrick Landen Granvel

(Last) (First) (Middle)
1410 LAKESIDE PARKWAY
SUITE 200

(Street)
FLOWER MOUND TX 75028

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MANNATECH INC [ MTEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
06/05/2025
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock Par Value $0.0001 Per Share 3,975 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Right to Purchase Common Stock $10.6 06/03/2025 A 20,000 (1) 06/03/2035 Common Stock, par value $0.0001 per share 20,000 $0 44,000 D
Explanation of Responses:
1. The Form 4 that was filed on 6/5/2025 was filed with the incorrect vesting schedule. The correct vesting schedule is one-third of the stock options vest on the first anniversary of the date of grant, another one-third of the stock options vest on the second anniversary of the date of grant and the remaining one-third of the stock options vest on the third anniversary of the date of grant.
Remarks:
Options will vest immediately in the event of a change in control.
Yasir Haider, Controller, by Power of Attorney 08/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What changes were made in the Form 4/A for Mannatech (MTEX)?

The Form 4/A corrects the vesting schedule for a 20,000-option grant to one-third vesting on each of the first three anniversaries of the 06/03/2025 grant date.

How many options and at what price were granted to the reporting person?

The report shows 20,000 options with an exercise price of $10.60 per share, expiring on 06/03/2035.

Did the reporting person buy or sell shares?

The filing shows a disposition of 3,975 shares of common stock on 06/03/2025.

What is the reporting person's total beneficial ownership after the transactions?

The Form 4/A reports 44,000 shares beneficially owned following the reported transactions.

Does the option vest immediately in any circumstance?

Yes. The remarks state that options will vest immediately in the event of a change in control.
Mannatech

NASDAQ:MTEX

MTEX Rankings

MTEX Latest News

MTEX Latest SEC Filings

MTEX Stock Data

17.45M
859.90k
54.76%
18.95%
0.46%
Food Distribution
Medicinal Chemicals & Botanical Products
Link
United States
FLOWER MOUND